Jin Dong-Chan, Yun Sung Ro, Lee Seoung Woo, Han Sang Woong, Kim Won, Park Jongha, Kim Yong Kyun
Department of Internal Medicine, The Catholic University of Korea, Seoul, Korea.
Department of Internal Medicine, Konyang University, Deajeon, Korea.
Kidney Res Clin Pract. 2015 Sep;34(3):132-9. doi: 10.1016/j.krcp.2015.08.004. Epub 2015 Aug 20.
The Korean Society of Nephrology (KSN) launched a nationwide official survey program about dialysis therapy in 1985. Nowadays, the accumulated data for 30 years by this "Insan Prof. Min Memorial end-stage renal disease (ESRD) Registry" program have been providing the essential information for dialysis clinical practice, academic nephrology research, and health management policy. We reviewed 30 years of data to identify important changes and implications for the future improvement of dialysis therapy in Korea. Hemodialysis patients, especially diabetics and elderly patients have increased in number very rapidly during recent years in Korea. The Korean prevalence rate of ESRD patients was about 70% of the United States and about 50% of Japan according to the international comparisons in the annual data report of United States Renal Data System. The blood pressure control, anemia control, and dialysis adequacy have continuously improved year by year. The importance of calcium and phosphorus control has also been increasing because of the increase in long-term dialysis patients. In addition, chronic dialysis complications should be closely monitored and dialysis modifications, such as hemodiafiltration therapy, might be considered. Because of the increase of private clinics and nursing hospitals in dialysis practice, the role of dialysis specialists and continuing education are thought to be essential. For strict cost-effective dialysis control of increasing elderly, diabetic, and long-term dialysis patients, the KSN ESRD patient registration should be run by the KSN and health ministry in cooperation, in which the dialysis fee reimbursement should be accompanied.
韩国肾脏病学会(KSN)于1985年启动了一项关于透析治疗的全国性官方调查项目。如今,通过这个“仁山闵教授纪念终末期肾病(ESRD)登记处”项目积累的30年数据,一直在为透析临床实践、肾脏病学术研究和健康管理政策提供重要信息。我们回顾了30年的数据,以确定韩国透析治疗未来改进的重要变化和启示。近年来,韩国血液透析患者,尤其是糖尿病患者和老年患者的数量增长非常迅速。根据美国肾脏数据系统年度数据报告中的国际比较,韩国ESRD患者的患病率约为美国的70%,日本的50%。血压控制、贫血控制和透析充分性逐年持续改善。由于长期透析患者的增加,钙磷控制的重要性也在增加。此外,应密切监测慢性透析并发症,并可考虑进行透析方式的调整,如血液透析滤过治疗。由于透析实践中私人诊所和护理医院的增加,透析专科医生的作用和继续教育被认为至关重要。为了对日益增加的老年、糖尿病和长期透析患者进行严格的成本效益透析控制,KSN ESRD患者登记应由KSN和卫生部合作进行,并应伴随透析费用报销。